Caty Ebel Bitoun

1.1k total citations · 1 hit paper
9 papers, 884 citations indexed

About

Caty Ebel Bitoun is a scholar working on Urology, Rheumatology and Gastroenterology. According to data from OpenAlex, Caty Ebel Bitoun has authored 9 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Urology, 6 papers in Rheumatology and 4 papers in Gastroenterology. Recurrent topics in Caty Ebel Bitoun's work include Urinary Bladder and Prostate Research (8 papers), Pelvic floor disorders treatments (6 papers) and Gastroesophageal reflux and treatments (4 papers). Caty Ebel Bitoun is often cited by papers focused on Urinary Bladder and Prostate Research (8 papers), Pelvic floor disorders treatments (6 papers) and Gastroesophageal reflux and treatments (4 papers). Caty Ebel Bitoun collaborates with scholars based in France, United Kingdom and Canada. Caty Ebel Bitoun's co-authors include Vik Khullar, David Weinstein, Zahava Gabriel, Dominic Muston, Christopher R. Chapple, Adrian Wagg, Amanda Darekar, Matthias Oelke, Martin C. Michel and Christopher Sexton and has published in prestigious journals such as Journal of the American Geriatrics Society, European Urology and British Journal of Urology.

In The Last Decade

Caty Ebel Bitoun

8 papers receiving 851 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

2008 601 citations Christopher R. Chapple, Vik Khullar et al. European Urology profile →

Peers

Caty Ebel Bitoun

UROLO

RHEUM

EPIDE

SURGE

GASTR

J. Cambronero Spain

Weining Volinn United States

Natalie Hills United Kingdom

Vasileios Sakalis Greece

Metin İshak Öztürk Türkiye

Nils Wåhlin Sweden

Barış Nuhoğlu Türkiye

Çağrı Akın Şekerci Türkiye

Unni M.M. Mooppan United States

Muammer Bozkurt Türkiye

J. Cambronero Spain

Caty Ebel Bitoun

777 ×1.0

UROLO

659 ×0.9

RHEUM

471 ×1.0

EPIDE

199 ×1.5

SURGE

28 ×0.5

GASTR

Citations per year, relative to Caty Ebel Bitoun Caty Ebel Bitoun (= 1×) peers J. Cambronero

Countries citing papers authored by Caty Ebel Bitoun

Since Specialization

Citations

This map shows the geographic impact of Caty Ebel Bitoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caty Ebel Bitoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caty Ebel Bitoun more than expected).

Fields of papers citing papers by Caty Ebel Bitoun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caty Ebel Bitoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caty Ebel Bitoun. The network helps show where Caty Ebel Bitoun may publish in the future.

Co-authorship network of co-authors of Caty Ebel Bitoun

This figure shows the co-authorship network connecting the top 25 collaborators of Caty Ebel Bitoun. A scholar is included among the top collaborators of Caty Ebel Bitoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caty Ebel Bitoun. Caty Ebel Bitoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

McCarthy, Géraldine, et al.. (2013). Introduction of an Infliximab Biosimilar (CT-P13): A Five-Year Budget Impact Analysis for the Treatment of Rheumatoid Arthritis in Ireland. Value in Health. 16(7). A558–A558. 30 indexed citations

2.

Khullar, Vik, Linda Cardozo, Con Kelleher, et al.. (2013). Effects of drug cessation after flexible‐dose fesoterodine in patients with overactive bladder. British Journal of Urology. 112(6). 820–829. 9 indexed citations

3.

Khullar, Vik, Christopher Sexton, Christine L. Thompson, et al.. (2013). The relationship between BMI and urinary incontinence subgroups: Results from EpiLUTS. Neurourology and Urodynamics. 33(4). 392–399. 85 indexed citations

4.

Wagg, Adrian, Vik Khullar, Martin C. Michel, et al.. (2013). Long‐term safety, tolerability and efficacy of flexible‐dose fesoterodine in elderly patients with overactive bladder: Open‐label extension of the SOFIA trial. Neurourology and Urodynamics. 33(1). 106–114. 40 indexed citations

5.

Wagg, Adrian, Vik Khullar, Daniela Marschall‐Kehrel, et al.. (2013). Flexible‐Dose Fesoterodine in Elderly Adults with Overactive Bladder: Results of the Randomized, Double‐Blind, Placebo‐Controlled Study of Fesoterodine in an Aging Population Trial. Journal of the American Geriatrics Society. 61(2). 185–193. 87 indexed citations

6.

Cardozo, Linda, Timothy L. Hall, John Ryan, et al.. (2012). Safety and efficacy of flexible-dose fesoterodine in British subjects with overactive bladder: insights into factors associated with dose escalation. International Urogynecology Journal. 23(11). 1581–1590. 24 indexed citations

7.

Wagg, Adrian, Vik Khullar, Daniela Marschall‐Kehrel, et al.. (2011). Efficacy and Tolerability of Fesoterodine in Older People With Overactive Bladder: Results of the Open-Label Phase of the SOFIA Trial. 1 indexed citations

8.

Wagg, Adrian, Vikram Khullar, Daniela Marschall‐Kehrel, et al.. (2011). 880 ASSESSMENT OF FESOTERODINE TREATMENT IN OLDER PEOPLE WITH OVERACTIVE BLADDER: RESULTS OF SOFIA, A DOUBLE-BLIND, PLACEBO- CONTROLLED PAN EUROPEAN TRIAL. European Urology Supplements. 10(2). 276–277. 7 indexed citations

9.

Chapple, Christopher R., Vik Khullar, Zahava Gabriel, et al.. (2008). The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. European Urology. 54(3). 543–562. 601 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact